Amyotrophic lateral sclerosis (ALS) is the most common rapidly progressive adult-onset
neurodegenerative disorder. There have been great advances in the management of …

Background Despite being one of the most devastating diseases known, there is little
evidence for diagnosing and managing patients with amyotrophic lateral sclerosis (ALS) …

The main aims in the care of individuals with amyotrophic lateral sclerosis (ALS) are to
minimize morbidity and maximize quality of life. Although no cure exists for ALS, supportive …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting
20,000 to 30,000 people in the United States. The mainstay of care of patients affected by …

Background: Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disorder
that is inevitably fatal. There are no effective treatments to stop or reverse the natural course …

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive motor neuron disease that poses
a myriad of clinical problems Patients with ALS are best treated in a multidisciplinary setting …

In this review, we summarize the most important recent developments in the treatment of
amyotrophic lateral sclerosis (ALS). In terms of disease-modifying treatment options, several …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting the motor
nervous system. It causes progressive and cumulative physical disabilities in patients, and …

Amyotrophic lateral sclerosis (ALS), first described by Jean-Martin Charcot in the 1870s, is
an age-related disorder that leads to degeneration of motor neurons. The disease begins …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that causes
muscle weakness, disability, and eventually death, with a median survival of three to five …